BioIQ Appoints Public Health Advisory Board to Support COVID-19 Population Health Efforts
BioIQ, a healthcare engagement and clinical adherence technology platform company, announces the formation of a Public Health Advisory Board. The board will offer guidance on BioIQ's COVID-19 solutions as well as the company's core analytics, testing and care navigation solutions, presently used by 30 health plans representing over two-thirds of covered US lives.
Those appointed to the BioIQ Public Health Advisory Board include:
Regina Benjamin MD, MBA – 18th US Surgeon General
Don Fetterolf MD, MBA – past President of the American College of Medical Quality
Michael Bauer MD, FACP – Medical director and clinical pathologist
Ashley Reynolds PhD, RN – BioIQ Chief Experience Officer
Joshua Sclar MD, MPH – BioIQ Chief Medical Officer
BioIQ continues to onboard additional advisors. Board members' collective expertise in public health crisis management will help the company prioritize COVID-19 testing program efforts, which will focus initially on vulnerable populations, healthcare workers and those supporting critical infrastructure. The board will also reinforce efforts to contribute to the worldwide base of knowledge on the disease so BioIQ and other organizations can learn, improve and get ahead of this virus as well as future outbreaks.